(Received for publication September 30, 1991) Amongnon-classical /Mactam antibiotics, considerable attention is being paid to the carbapenems and penems1*. So far, the possibility of oral administration, either as such (Suntory SUN 55552)) or after ester-type prodrug derivatization (Farmitalia Carlo Erba FCE 228913) ), has been a distinct advantage of the penems over the carbapenem family. New orally active penems should combine superior biological properties with production costs acceptable in a price-sensitive market. On this basis FCE 25199 (2), the (5-methyl-2-oxo-l,3-dioxol-4-yl)methyl ester of (5R,6S)-6-[(/?)-l -hydroxyethyl]-2-methoxymethylpenem-3-carboxylic acid (1; FCE 249644)), was selected for further studies. Structurally related to the oral cephalosporin cefpodoxime5) because of the methoxymethyl substituent, FCE 25199 features a new prodrug moiety6), also found in lenampicillin7) and cefcanel daloxate8), which is claimed to release non-toxic metabolites in vivo9 The alkylation of acid ll, and the contaminants present in the product 12 (which cannot be purified without extensive loss), were found to be critical for the yield of the overall sequence. Taking advantage of the possibility of, converting the 4-bromomethyldioxole 6 to the stable carbinol 713'14)? which has no equivalent in conventional reagents for the synthesis ofester-type prodrugs1 5), we found that the oxalimide ester 12 could be cleanly prepared by simply adding 7 and a second equivalent of triethylamine to a cold solution of 10 resulting, as above described, from reaction of 9 and oxalyl chloride. The whole sequence was nowaccomplished /?-Lactamase producers. c Chemical half-lives (HPLC determination) at 37°C, 0.2m phosphate buffer, 0.2mg/ml initial concentration, in the presence of 5% CH3CNas solubilizing vehicle. NT-not tested. in appreciably higher yields (50~55%). Similar results were obtained1°'16) when the oxalimide 12 was prepared by acylation of the azetidinone 9 with the more elaborate dioxolemethyl chloro-oxalate synthon 8*. On preparations up to kilogram scale we found the two-step/one-pot reaction of the acid chloride 10 with the alcohol 7 more practical. The in vitro activity of the parent compound FCE 24964 in comparison with other orally absorbed /Mactams, including SUN 5555 (prepared in our laboratories according to a published procedure1 8)), is shown in Table 1 . This simple penem molecule is endowed with potent and broad antibacterial activity against Gram-positive and Gram-negative organisms (except Pseudomonasspp.), regardless of /Mactamase production. Also strains resistant to f After completion of our studies, the preparation and use of this reagent for the synthesis of a related penem was reported by Sankyo17).
newer cephalosporins, such as Enterobacter cloacae P99 and Klebsiella aerogenes 1082E, are inhibited by FCE 24964. The high degree of bactericidal activity of FCE 24964 is documented in Table 2 ; with the exception of Streptococcus faecalis, the MBC/MICratio is constantly low ( < 2). Relatively good stability to porcine renal dehydropeptidase was observed in vitro; under conditions previously reported19), the calculated specifity constant (VmsLx/Km) of the enzyme (1 fig/ml Preliminary data on the efficacy of FCE 25199 in mouse systemic infections, in comparison with the two oral penems under clinical evaluation and cefixime, are presented in Table 4 . In these experiments the four compounds were tested in parallel against the listed pathogens. The ED5Osfor FCE 25199 and FCE 22891 were comparable, and always lower than those of SUN5555. In conclusion, FCE 25199 merits further development to assess its absorption and pharmacokinetics after oral dosing in humans.
